Example: dental hygienist
Sciences, Inc. at 1
(NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults Sciences, Inc. at 1 and pediatric patients weighing at least 14 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION should only be …
www.gilead.com1 INDICATIONS AND USAGE . 1.1 HIV-1 Infection . VIREAD ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gilead.com3 full prescribing information warning: posttreatment acute exacerbation of hepatitis b and risk of drug resistance with use of truvada for hiv-1 pre-
-800 GILEAD5 or FDA at 1800 FDA 1088 or …
www.gilead.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information
AmBisome (amphotericin B) liposome for injection
www.gilead.com5 Pediatric and Elderly Patients The pharmacokinetics of amphotericin B after administration of AmBisome in pediatric and elderly patients has not been studied; however, AmBisome has
(incidence greater than or equal to 10%, Grades 2
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIREAD safely and effectively. DSee full prescribing information …
for BIKTARVY. BIKTARVY ...
www.gilead.comGilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.
AMENDED AND RESTATED LICENSE AGREEMENT …
www.gilead.comFinal Version 1 AMENDED AND RESTATED LICENSE AGREEMENT (TEMPLATE) This AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of July __, 2011 (the “Effective Date”) by and between Gilead Sciences, Inc. a
HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, …
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, or 6 These highlights do not include all the information needed to use HARVONI ® safely and effectively. See full prescribing information
LETAIRIS for LETAIRIS ...
www.gilead.com2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.
MEDICATION GUIDE ZYDELIG (zye-DEL-ig) …
www.gilead.comMEDICATION GUIDE ZYDELIG® (zye-DEL-ig) (idelalisib) tablets What is the most important information I should know about Zydelig? Zydelig can cause serious side effects that can lead to death, including:
Related documents
Guidelines on Use Antiretroviral Drugs for Treating and ...
chskenya.orgThe 2018 edition of the ‘Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya’ is an update of the comprehensive HIV prevention and treatment guidelines released in 2016. The MOH releases updated HIV prevention and treatment guidelines in line with emerging evidence every 2 years.
Updated Guidelines for Antiretroviral Postexposure ...
www.cdc.govhealth care providers who have expertise in antiretroviral medication use for similar patients (e.g., children, pregnant women, or those with such comorbid conditions as impaired renal function). [VII-C] [VII-E2] • All persons evaluated for possible nPEP should be provided any indicated prevention, treatment, or
CLINICAL GUIDELINES: 4 ANTIRETROVIRAL THERAPY
www.who.int74 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection The following principles may inform future guidance. • Treatment should be started based on a person’s informed decision to initiate ART.
A TIMELINE OF HIV/AIDS
www.hiv.govpeople to seek treatment. • By year’s end, there is a cumulative total of 270 reported cases of severe immune deiciency among gay men, and 121 of those individuals have died. Some researchers begin calling the condition. GRID (Gay-Related Immune Deiciency). This terminology inluences both the medical profession and the
Antiretroviral drug chart - Aidsmap
www.aidsmap.comAntiretroviral drug chart Integrase inhibitors Dolutegravir 50mg tablet 1 or 2 Common: Nausea, diarrhoea, headache, rash, itching, vomiting, abdominal pain or discomfort, difficulty in sleeping, dizziness, abnormal dreams, fatigue, flatulence, increase in liver enzymes, increase in creatine phosphokinase (enzymes produced in the muscles)